ストックスクリーナーアプリを入手
54.96
1.99%
1.07
アフターアワーズ：
54.90
-0.06
-0.11%
前日終値:
$53.89
開ける：
$54.09
24時間の取引高:
2.81M
Relative Volume:
1.35
時価総額：
$6.58B
収益：
$18.47M
当期純損益:
$-589.53M
株価収益率:
-10.45
EPS:
-5.26
ネットキャッシュフロー:
$-399.80M
1週間 パフォーマンス:
+13.20%
1か月 パフォーマンス:
+55.56%
6か月 パフォーマンス:
+36.75%
1年 パフォーマンス:
+4.09%
1日の値動き範囲:
$53.57
$55.91
1週間の範囲:
$47.22
$55.91
52週間の値動き範囲:
$29.31
$59.39
Cytokinetics Inc Stock (CYTK) Company Profile
名前
Cytokinetics Inc
セクター
電話
(650) 624-3000
住所
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
CYTK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CYTK
Cytokinetics Inc
|
54.96 | 6.45B | 18.47M | -589.53M | -399.80M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | 再開されました | Raymond James | Mkt Perform |
| 2025-04-24 | 開始されました | Barclays | Overweight |
| 2025-02-07 | 開始されました | Citigroup | Buy |
| 2025-01-22 | 開始されました | Stifel | Buy |
| 2024-11-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-13 | ダウングレード | Goldman | Buy → Neutral |
| 2024-01-24 | ダウングレード | UBS | Buy → Neutral |
| 2024-01-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-09 | 開始されました | Goldman | Buy |
| 2023-11-07 | 開始されました | B. Riley Securities | Buy |
| 2023-08-15 | 開始されました | SVB Securities | Outperform |
| 2023-02-17 | 開始されました | BofA Securities | Neutral |
| 2022-12-23 | 繰り返されました | Needham | Buy |
| 2022-12-20 | 開始されました | Truist | Buy |
| 2022-10-11 | 開始されました | UBS | Buy |
| 2022-01-28 | 開始されました | Goldman | Buy |
| 2021-12-22 | 開始されました | Oppenheimer | Outperform |
| 2021-12-10 | 開始されました | JP Morgan | Overweight |
| 2021-10-07 | 開始されました | Jefferies | Buy |
| 2021-03-12 | 開始されました | Wolfe Research | Outperform |
| 2021-02-18 | 開始されました | Barclays | Overweight |
| 2021-01-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-29 | 開始されました | Goldman | Neutral |
| 2020-07-10 | 開始されました | Raymond James | Strong Buy |
| 2020-05-05 | 開始されました | Mizuho | Buy |
| 2020-04-09 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-10 | 再開されました | Morgan Stanley | Equal-Weight |
| 2017-11-22 | 繰り返されました | Morgan Stanley | Overweight |
| 2017-11-22 | ダウングレード | Needham | Strong Buy → Buy |
| 2017-11-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-07-31 | 開始されました | Morgan Stanley | Overweight |
| 2017-03-08 | 開始されました | Rodman & Renshaw | Buy |
| 2017-02-06 | アップグレード | Needham | Buy → Strong Buy |
| 2016-12-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2016-07-28 | 繰り返されました | Needham | Buy |
| 2015-11-10 | 繰り返されました | FBR Capital | Outperform |
| 2015-11-09 | 繰り返されました | ROTH Capital | Buy |
| 2015-07-24 | 繰り返されました | MLV & Co | Buy |
| 2014-12-31 | 繰り返されました | ROTH Capital | Buy |
| 2014-11-04 | アップグレード | MLV & Co | Hold → Buy |
| 2014-04-28 | 繰り返されました | Needham | Buy |
すべてを表示
Cytokinetics Inc (CYTK) 最新ニュース
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, - GlobeNewswire
Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokineti - GuruFocus
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm - MarketScreener
Cytokinetics, Incorporated Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCYTK - MarketScreener
Shareholders SueWallSt in New Class Action Against Cytokinetics, IncorporatedAct Now - Nasdaq
Why Cytokinetics Incorporated (KK3A) stock appears on watchlistsQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK) - Defense World
CYTK Stockholders With Large Losses Should Contact Robbins LLP For Information About The Cytokinetics, Inc. Securities Fraud Class Action - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Cytokinetics, Incorporated (CYTK) Investors of November 17, 2025 Deadline - ACCESS Newswire
HC Wainwright & Co. Reiterates Cytokinetics (CYTK) Buy Recommendation - Nasdaq
Should I hold or sell Cytokinetics Incorporated stock in 2025Quarterly Profit Summary & Daily Market Momentum Tracking - newser.com
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Shareholders who lost money in shares of Cytokinetics, - GlobeNewswire
How Cytokinetics Incorporated stock benefits from tech adoptionJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Cytokinetics, Incorporated Securities Lawsuit Investigation - Claim Depot
Cytokinetics (CYTK) Receives Reiterated 'Buy' Rating with $120 T - GuruFocus
Cytokinetics (NASDAQ:CYTK) Earns "Buy" Rating from HC Wainwright - MarketBeat
Published on: 2025-09-29 10:40:49 - newser.com
Investors Buy Large Volume of Cytokinetics Call Options (NASDAQ:CYTK) - MarketBeat
Can Cytokinetics Incorporated (KK3A) stock sustain breakout momentumJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Strategies to average down on Cytokinetics IncorporatedJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Should I buy Cytokinetics Incorporated (KK3A) stock before earnings seasonGDP Growth & Safe Entry Trade Reports - newser.com
Cytokinetics, Inc. Experiences Evaluation Revision Amidst Evolving Market Dynamics - Markets Mojo
Cytokinetics (CYTK) Reveals Promising Aficamten Data at Heart Fa - GuruFocus
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Cytokinetics presents new data related to aficamten - MarketScreener
Cytokinetics Announces Positive Data on Aficamten's Impact on Exercise Capacity and Long-Term Efficacy at HFSA Annual Scientific Meeting 2025 - Quiver Quantitative
Cytokinetics Presents New Data Related To Aficamten - TradingView
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 - Yahoo Finance
Cytokinetics Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Lost Money on Cytokinetics, Incorporated (CYTK)? Contact Levi & Korsinsky to Join Class Action Before November 17, 2025 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming DeadlinesCYTK - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel - Caledonian Record
What drives Cytokinetics Incorporated KK3A stock priceMarket Sentiment Indicators & Small Entry Cost Trading - earlytimes.in
Can Cytokinetics Incorporated (KK3A) stock expand revenue streamsRate Cut & Daily Profit Maximizing Trade Tips - newser.com
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, I - PR Newswire
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) InvestorsContact Levi & Korsinsky Before November 17, 2025 - ACCESS Newswire
Class Action Filed Against Cytokinetics, Incorporated (CYTK)November 17, 2025 Deadline to JoinContact Levi & Korsinsky - Morningstar
Published on: 2025-09-26 01:51:19 - newser.com
November 17, 2025 Deadline Approaching: Join Class Action Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - Newsfile
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025CYTK | FinancialContent - FinancialContent
Shareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
FY2025 Earnings Estimate for Cytokinetics Issued By B. Riley - Defense World
Cytokinetics, Inc. Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the CYTK Class Action Lawsuit - Eastern Progress
Cytokinetics Inc (CYTK) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):